Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study

Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study

IntroductionMacrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) cases have been rapidly increasing. The primary reason for this increased incidence is the pathogen's acquisition of resistance through mutations in 23S rRNA genes. Due to the unfeasibility of testing for macrolide susce...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yun Li, Yunwei Liu, Xinying Chen, Xiaolan Xiao, Yiting Chen, Lianyu Wang, Wenwen Jiang, Jinghua Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Pediatrics
Subjects:	macrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) macrolide-sensitive Mycoplasma pneumoniae pneumonia (MSMP) clinical characteristics predictive indictors early and appropriate treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2024.1489389/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan
by: Chih-Hao Chang, et al.
Published: (2021-09-01)

Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia
by: Wei-Chao Liao, et al.
Published: (2025-07-01)

Treatment modalities for fever duration in children with Mycoplasma pneumoniae pneumonia
by: Dayun Kang, et al.
Published: (2025-04-01)

Clinical features associated with macrolides resistance of Mycoplasma pneumoniae pneumonia in children: a single-center analysis
by: Shuzhen Han, et al.
Published: (2025-07-01)

The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
by: Leng M, et al.
Published: (2024-10-01)

Case Report: A neonatal case of severe congenital Mycoplasma pneumoniae pneumonia with atelectasis and macrolide resistance
by: Dan Wang, et al.
Published: (2025-06-01)

Therapeutic efficacy of lascufloxacin in patients with Mycoplasma pneumoniae pneumonia
by: Naoyuki Miyashita, et al.
Published: (2025-08-01)

Comparative characteristics of typical and atypical (Mycoplasma) pneumonia in children
by: T. A. Britkova, et al.
Published: (2021-07-01)

Macrolide resistance in Mycoplasma pneumoniae in adult patients
by: Panpan Xie, et al.
Published: (2025-03-01)

Early identification and treatment of macrolide-resistant severe Mycoplasmal pneumoniae pneumonia in children
by: YU MAN, et al.
Published: (2025-04-01)

Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
by: Yuqian Zhang, et al.
Published: (2025-01-01)

Clinical impact of rapid test for macrolide-resistance gene mutation among cases with Mycoplasma pneumoniae in Japan
by: Masayuki Murata, et al.
Published: (2025-11-01)

Case Report: Positive Mycoplasma pneumoniae IgM does not necessarily indicate acute infection: two case studies
by: Hao Wang, et al.
Published: (2025-05-01)

Increased in vitro antimicrobial resistance of Mycoplasma pneumoniae isolates obtained from children in Beijing, China, in 2023
by: Xinyu Jia, et al.
Published: (2024-12-01)

Treatment of community-acquired pneumonia using the modern therapeutical guides
by: Škodrić-Trifunović Vesna, et al.
Published: (2006-01-01)

Risk factor analysis of plastic bronchitis among 126 children with macrolide-resistant Mycoplasma pneumoniae pneumonia with mutations at the A2063G site after bronchoscopy examination: a nomogram prediction model
by: Ran Ma, et al.
Published: (2025-02-01)

Chest CT characterization of children with necrotizing pneumonia due to Mycoplasma pneumoniae infection
by: Jiapu Hou, et al.
Published: (2025-02-01)

Epidemiological changes of Mycoplasma pneumoniae among children before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024
by: Jiahui Qi, et al.
Published: (2025-07-01)

Analysis of the characteristics of mixed infections with Mycoplasma pneumoniae in children
by: Li Yuan, et al.
Published: (2025-03-01)

Characterizing the epidemiology of Mycoplasma pneumoniae infections in China in 2022–2024: a nationwide cross-sectional study of over 1.6 million cases
by: Yamin Sun, et al.
Published: (2025-12-01)

Case Report: Refractory Mycoplasma pneumoniae pneumonia complicated by pulmonary embolism and infarction in a child
by: Jianqin Zhang, et al.
Published: (2025-06-01)

Serum LDH and its isoenzymes (LDH2 and LDH5) associated with predictive value for refractory mycoplasma pneumoniae pneumonia in children
by: Lv Jun, et al.
Published: (2025-06-01)

Atelectasis predicts poor prognosis in pediatric macrolides-unresponsive Mycoplasma pneumoniae pneumonia with A2063/2064G mutations treated with azithromycin
by: Jie Cheng, et al.
Published: (2025-06-01)

Predicting and interpreting key features of refractory Mycoplasma pneumoniae pneumonia using multiple machine learning methods
by: Yuhan Jiang, et al.
Published: (2025-05-01)

Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany
by: Frederike Waldeck, et al.
Published: (2025-03-01)

Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP
by: Yu HUANG, et al.
Published: (2025-08-01)

The impact of atopy on the clinical characteristics of mycoplasma pneumoniae pneumonia in pediatric patients
by: Yujie Qin, et al.
Published: (2025-01-01)

Compassionate Use of Omadacycline in a Down Syndrome Pre-Schooler With Critically Ill Atypical Pneumonia Caused by Macrolide-Resistant Mycoplasma Pneumoniae
by: Wu D, et al.
Published: (2025-01-01)

Establishment and validation of a predictive model for Lobar pneumonia caused by Mycoplasma pneumoniae infection in children
by: Yonghan Luo, et al.
Published: (2025-07-01)

Prediction model for severe mycoplasma pneumoniae pneumonia and analysis of macrolide-resistance in children: a case-control study
by: Shaoying Liu, et al.
Published: (2025-06-01)

Evidence‐based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023)
by: The Subspecialty Group of Respiratory, the Society of Pediatrics, Chinese Medical Association, et al.
Published: (2025-03-01)

Predictive value of plasma sB7-H3 and YKL-40 in pediatric refractory Mycoplasma pneumoniae pneumonia
by: Zhao QiuMin, et al.
Published: (2025-01-01)

Comparative characteristics of pneumonia caused by <i>Mycoplasma pneumoniae</i> in children
by: S. L. Bevza, et al.
Published: (2023-10-01)

Clinical characteristics and risk factors for Mycoplasma pneumoniae pneumonia in children
by: Xueqi Zhao, et al.
Published: (2024-12-01)

Assessment of serum parameters caused by the outbreak of mycoplasma pneumoniae pneumonia in children after COVID-19
by: Fangye Zhou, et al.
Published: (2025-08-01)

D-dimer serves as predictor of plastic bronchitis or necrotizing pneumonia in children with Mycoplasma pneumoniae pneumonia
by: Yanke Yue, et al.
Published: (2025-07-01)

Comparative analysis of the clinical characteristics of severe Mycoplasma pneumoniae pneumonia and severe bacterial pneumonia in children
by: Jie Liu, et al.
Published: (2025-05-01)

Development and validation of a nomogram for predicting necrotizing pneumonia in children with refractory Mycoplasma pneumoniae pneumonia
by: Xiaoying Li, et al.
Published: (2025-05-01)

Clinical characteristics of Mycoplasma pneumoniae pneumonia with airway involvement in children
by: Baoying Zheng, et al.
Published: (2025-03-01)

Characterization of diffuse lung function in children with Mycoplasma pneumoniae pneumonia
by: Li Wang, et al.
Published: (2025-01-01)